{"id":122006,"date":"2017-06-14T12:10:36","date_gmt":"2017-06-14T12:10:36","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=122006"},"modified":"2017-06-14T12:10:36","modified_gmt":"2017-06-14T12:10:36","slug":"overview-of-diasource-immunoassays-sa-market-research-new-study-analysis-product-pipeline-analysis-2017-update","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/overview-of-diasource-immunoassays-sa-market-research-new-study-analysis-product-pipeline-analysis-2017-update_122006.html","title":{"rendered":"Overview Of DIAsource ImmunoAssays SA – Market Research, New Study, Analysis, Product Pipeline Analysis, 2017 Update"},"content":{"rendered":"
\"\"<\/a><\/p>\n
\n
“MarketResearchReports.Biz\/DIAsource ImmunoAssays SA”<\/div>\n<\/div>\n<\/div>\n
The report analyzes and presents an overview on “DIAsource ImmunoAssays SA – Product Pipeline Analysis, 2017 Update” worldwide.<\/div>\n

Recent research and the current scenario as well as future market potential of “<\/span>\u200bDIAsource ImmunoAssays SA<\/a><\/strong> – Product Pipeline Analysis, 2017 Update” globally.<\/strong><\/span><\/p>\n

\u200bDIAsource ImmunoAssays SA (DIAsource), formerly BioSource Europe SA, a subsidiary of Anteo Diagnostics Ltd is a diagnostics company that develops, manufactures and markets clinical diagnostic products. The companys products comprise immunoassays, antibodies, instruments and RUO products. Its antibodies comprise osteocalcin, adrenocorticotropic hormone, adiponectin, aggrecan, calcitonin, alpha-fetoprotein, parathyroid hormone, carcino embryonic antigen, placental lactogen and thyroid stimulating hormone. DIAsources instruments comprise neptune instrument, automated system, ELISA reader, shaker, and washer. The company offers products in the fields of cardiovascular and salt balance, auto-immunity, gastrointestinal metabolism and fertility. It markets products in Belgium and abroad. DIAsource is headquartered in Louvain-La-Neuve, Belgium.<\/span><\/p>\n

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.<\/p>\n

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.<\/p>\n

Request For The Sample Copy Of This Report @ \u200bhttp:\/\/www.marketresearchreports.biz\/sample\/sample\/1149982<\/a><\/strong><\/p>\n

Scope:<\/strong><\/p>\n

– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company DIAsource ImmunoAssays SA
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.<\/p>\n

Browse more medical equipment market research reports @ \u200bhttp:\/\/www.marketresearchreports.biz\/category\/109<\/a><\/strong><\/p>\n

Reasons to Buy:<\/strong><\/p>\n

– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio<\/p>\n

Note: Some sections may be missing if data is unavailable for the company<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Marketresearchreports.biz
Contact Person:<\/strong> Swapnil
Email:<\/strong> sales@marketresearchreports.biz
Phone:<\/strong> 866-997-4948
Address:<\/strong>State Tower 90 State Street, Suite 700
City:<\/strong> Albany
State:<\/strong> NY 12207
Country:<\/strong> United States
Website:<\/strong> http:\/\/www.marketresearchreports.biz<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“MarketResearchReports.Biz\/DIAsource ImmunoAssays SA” The report analyzes and presents an overview on “DIAsource ImmunoAssays SA – Product Pipeline Analysis, 2017 Update” worldwide. Recent research and the current scenario as well as future market potential of “\u200bDIAsource ImmunoAssays SA – Product Pipeline Analysis, … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-122006","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/122006","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=122006"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/122006\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=122006"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=122006"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=122006"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}